Sugi Predict

Sugi Predict / Compounds / SCHEMBL685071

SCHEMBL685071

SCHEMBL685071

C=Cc1ccc(C(=O)OC)c(O)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA12 O43570 3/20 0.61
▸ CA1 P00915 3/20 0.61
▸ CA2 P00918 3/20 0.61
▸ CA7 P43166 3/20 0.61
▸ CA9 Q16790 3/20 0.61
▸ CA14 Q9ULX7 3/20 0.61
▸ PDK2 Q15119 1/20 0.61
▸ PDK4 Q16654 1/20 0.61
▸ GAA P10253 2/20 0.57
▸ SMN1; SMN2 Q16637 2/20 0.53
▸ LMNA P02545 2/20 0.50
▸ TRPA1 O75762 1/20 0.50
▸ MYC P01106 1/20 0.50
▸ TSHR P16473 1/20 0.50
▸ PTGS2 P35354 1/20 0.50
▸ PTPN1 P18031 1/20 0.47
▸ APP P05067 3/20 0.45
▸ EGFR P00533 2/20 0.44
▸ TTR P02766 1/20 0.42
▸ MAPT P10636 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL685901 0.86 PTGS2 (0.67) CA12CA1CA2CA7CA9
SCHEMBL30263061 0.86 PTGS2 (0.49) CA12CA1CA2CA7CA9
SCHEMBL3892038 0.86 PTGS2 (0.49) CA12CA1CA2CA7CA9
SCHEMBL358930 0.84 CA12 (0.62) CA12CA1CA2CA7CA9
SCHEMBL10165329 0.83 KDM4E (0.45) CA12CA1CA2CA7CA9
SCHEMBL25561430 0.82 TRPA1 (0.42) CA12CA1CA2CA7CA9
SCHEMBL15778474 0.81 CA12 (0.42) CA12CA1CA2CA7CA9
SCHEMBL16960362 0.81 CA12 (0.42) CA12CA1CA2CA7CA9
SCHEMBL1164209 0.81 ABL1 (0.46) CA12CA1CA2CA7CA9
SCHEMBL12339910 0.81 PTGS2 (0.45) CA12CA1CA2CA7CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 165 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-57105413-A — — None — — JP disclosed
US-20260092052-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUND TAKEDA PHARMACEUTICALS CO (JP) 2026-04-02 — — US disclosed
US-20260069602-A1 COMPOUNDS, COMPOSITIONS, AND METHODS ACONCAGUA BIO INC (US) 2026-03-12 — — US disclosed
US-20240109874-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUND TAKEDA PHARMACEUTICALS CO (JP) 2024-04-04 — — US disclosed
US-20220411413-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUND TAKEDA PHARMACEUTICALS CO (JP) 2022-12-29 — — US disclosed
US-10899752-B2 2,3-dihydro-4H-1,3-benzoxazin-4-one derivatives as modulators of cholinergic muscarinic M1 receptor TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2021-01-26 — — US disclosed
US-20210009572-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUND TAKEDA PHARMACEUTICALS CO (JP) 2021-01-14 — — US disclosed
US-10865200-B2 Nitrogen-containing heterocyclic compound TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2020-12-15 — — US disclosed
EP-3313836-B1 2,3-DIHYDRO-4H-1,3-BENZOXAZIN-4-ONE DERIVATIVES AS MODULATORS OF CHOLINERGIC MUSCARINIC M1 RECEPTOR TAKEDA PHARMACEUTICALS CO (JP) 2020-11-11 — — EP disclosed
EP-3134386-B1 ISOINDOLINE-1-ONE DERIVATIVES AS CHOLINERGIC MUSCARINIC M1 RECEPTOR POSITIVE ALLOESTERIC MODULATOR ACTIVITY FOR THE TREATMENT OF ALZHEIMERS DISEASE TAKEDA PHARMACEUTICALS CO (JP) 2020-05-20 — — EP disclosed
WO-2007022269-A2 COMPOUNDS AND COMPOSITIONS AS TPO MIMETICS IRM LLC (BM) 2007-02-22 — — WO disclosed
WO-2007022269-A2 COMPOUNDS AND COMPOSITIONS AS TPO MIMETICS IRM LLC (BM) 2007-02-22 — — WO disclosed
EP-0570932-B1 Styrenic block copolymer and process for producing same IDEMITSU KOSAN CO (JP) 1997-07-23 — — EP disclosed
US-5418290-A Compatability with other resins, adhesion IDEMITSU KOSAN CO., LTD. (JP) 1995-05-23 — — US disclosed
US-5391626-A Syndiotactic, high performance, compatibility and adhesiveness; molding materials IDEMITSU KOSAN CO., LTD. (JP) 1995-02-21 — — US disclosed
EP-0457332-B1 Polymerizable carbonates having ethylenic and acetylenic functions NIPPON PAINT CO LTD (JP) 1994-10-26 — — EP disclosed
EP-0570932-A2 Styrenic block copolymer and process for producing same IDEMITSU KOSAN COMPANY LIMITED (JP) 1993-11-24 — — EP disclosed
US-5194655-A POLYMERIZABLE CARBONATES HAVING ETHYLENIC AND ACETYLENIC FUNCTIONS NIPPON PAINT COMPANY, LIMITED (JP) 1993-03-16 — — US disclosed
EP-0457332-A1 Polymerizable carbonates having ethylenic and acetylenic functions NIPPON PAINT CO., LTD. (JP) 1991-11-21 — — EP disclosed
JP-S57105413-A COPOLYMER FOR LENS SEIKO EPSON CORP 1982-06-30 — — JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10899752-B2 2,3-dihydro-4H-1,3-benzoxazin-4-one derivatives as modulators of cholinergic muscarinic M1 receptor CHRM1, CHRM4, CHRM2 CA12 2620/4885CA1 1517/4885CA2 1820/4885
US-10865200-B2 Nitrogen-containing heterocyclic compound CHRM1, CHRM5, CHRM2 CA12 3642/4885CA1 1743/4885CA2 2423/4885
US-20240109874-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUND CHRM1, CHRM5, CHRM2 CA12 3642/4885CA1 1743/4885CA2 2423/4885
US-20260092052-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUND CHRM1, CHRM2, CHRM4 CA12 2752/4885CA1 871/4885CA2 1084/4885
US-20220411413-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUND CHRM1, CHRM5, CHRM2 CA12 3642/4885CA1 1743/4885CA2 2423/4885
US-20210009572-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUND CHRM1, CHRM5, CHRNA5 CA12 3863/4885CA1 2620/4885CA2 2344/4885
US-20260069602-A1 COMPOUNDS, COMPOSITIONS, AND METHODS SCTR, SSTR1, NPY1R CA12 1070/4885CA1 1131/4885CA2 672/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.